Total investment proposed up to USD 350 million
Fortis Healthcare announced that on 17 April 2018 has received an unsolicited non-binding expression of interest from Fosun Health Holdings , a wholly owned subsidiary of Fosun International ('Fosun International'), a company listed on the Hong Kong Stock Exchange with a proposal of primary infusion at a price upto Rs. 156/share, subject to due diligence to be completed within three weeks, upto a total investment of USD 350 million (including a preliminary investment of upto Rs 100 crore) and further subject to certain conditions as mentioned in the offer letter.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
